NPMFF yields 66666666.67% · PFE yields 6.13%● Live data
📍 NPMFF pulled ahead of the other in Year 1
Combined, NPMFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPMFF + PFE for your $10,000?
NewPeak Metals Limited, a mineral resource company, explores for and evaluates gold properties in Finland, New Zealand, and Argentina. Its project portfolio includes the Las Opeñas Gold project covering an area of 1,462 hectares located in the north-western region of San Juan province, Argentina; and Cachi Gold project covering an area of 46,892 hectares lease package located in the central-western region of Santa Cruz province, Argentina. The company also holds 100% interest in the Somero and Tampere Gold Project covering a total area of 286 hectares located in Finland; and holds interest in the Bergslagen Tungsten project covering a total area of 11,870 hectares located near the city of Grängesberg, Sweden. In addition, it owns approximately 22.10% interest in Lakes Blue Energy which has petroleum assets located in Victoria, Queensland, South Australia, and Papua New Guinea. The company was formerly known as Dark Horse Resources Limited and changed its name to NewPeak Metals Limited in September 2020. NewPeak Metals Limited was incorporated in 1995 and is based in Brisbane, Australia.
Full NPMFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.